
VIJAYPD
Vijaypd Ceutical Limited
- IPO Status
- Closed
- Open Date
- 29 Sep 2025
- Close Date
- 1 Oct 2025
IPO Details
- Min. Investment
- ₹2,80,000
- Price Band
- ₹35
- Lot Size
- 4000 shares
- Issue Size
- ₹19 Cr
- Face Value
- 10
- IPO Doc
- —
Schedule
- IPO open29 Sep 2025
- IPO close date1 Oct 2025
- Allotment date3 Oct 2025
- Funds unblock or debit6 Oct 2025
- Listing date7 Oct 2025
Financial Performance
- Revenue
- Profit
Stocks similar to VIJAYPD
- MedPlus Health Services Limited
- Entero Healthcare Solutions Limited
FAQs
Vijaypd Ceutical Limited IPO is a SME IPO aggregating up to ₹19 Cr, with equity shares of face value ₹10 each. The shares are proposed to be listed on NSE.
The Vijaypd Ceutical Limited IPO opened on 29 Sep 2025 and closed on 1 Oct 2025. IPO Period: 29 Sep 2025 – 1 Oct 2025.
The price band for the Vijaypd Ceutical Limited IPO is ₹35 per share. Investors can bid within the specified price band, subject to the applicable IPO rules.
The minimum lot size is 4,000 shares. At the upper price band of ₹35, the minimum investment required is ₹2,80,000.
Particular Details Lot Size 4,000 shares Minimum Application 8,000 shares Price Band ₹35 Minimum Investment ₹2,80,000 Here is the timeline for the Vijaypd Ceutical Limited IPO:
IPO Event Date IPO Opens 29 Sep 2025 IPO Closes 1 Oct 2025 UPI Mandate Deadline 1 Oct 2025, 5:00 PM Basis of Allotment 3 Oct 2025 Refund Initiation 6 Oct 2025 Shares Credited 6 Oct 2025 Listing Date 7 Oct 2025 The basis of allotment for the Vijaypd Ceutical Limited IPO is expected to be finalised on 3 Oct 2025. Investors can check their allotment status through the registrar or relevant stock exchange website using their application details. Registrar: KFin Technologies.
The equity shares of Vijaypd Ceutical Limited are proposed to be listed on NSE. Proposed Listing Date: 7 Oct 2025.
The key financial performance of Vijaypd Ceutical Limited is:
Financial Year Revenue Profit FY24 ₹59.21 Cr ₹1.65 Cr FY25 ₹100.23 Cr ₹4.71 Cr FY26 ₹98.96 Cr ₹5.06 Cr Revenue CAGR: 29.3% | Profit CAGR: 75.1%. Figures are as disclosed in the company's offer documents.


